This is a Validated Antibody Database (VAD) review about human TRDMT1, based on 2 published articles (read how Labome selects the articles), using TRDMT1 antibody in all methods. It is aimed to help Labome visitors find the most suited TRDMT1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TRDMT1 synonym: DMNT2; DNMT2; MHSAIIP; PUMET; RNMT1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (A-7)
  • western blot knockout validation; human; loading ...; fig 1a
Santa Cruz Biotechnology TRDMT1 antibody (Santa, sc-271513) was used in western blot knockout validation on human samples (fig 1a). Aging (Albany NY) (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-9)
  • western blot knockout validation; human; 1:400; loading ...; fig 1c
  • immunocytochemistry; human; loading ...; fig 2e
  • immunohistochemistry; human; 1:200; loading ...; fig 5f
Santa Cruz Biotechnology TRDMT1 antibody (Santa Cruz Biotechnology, sc-365001) was used in western blot knockout validation on human samples at 1:400 (fig 1c), in immunocytochemistry on human samples (fig 2e) and in immunohistochemistry on human samples at 1:200 (fig 5f). NAR Cancer (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-7)
  • western blot knockout validation; human; loading ...; fig 1a
Santa Cruz Biotechnology TRDMT1 antibody (Santa, sc-271513) was used in western blot knockout validation on human samples (fig 1a). Aging (Albany NY) (2021) ncbi
mouse monoclonal (D-9)
  • western blot knockout validation; human; 1:400; loading ...; fig 1c
  • immunocytochemistry; human; loading ...; fig 2e
  • immunohistochemistry; human; 1:200; loading ...; fig 5f
Santa Cruz Biotechnology TRDMT1 antibody (Santa Cruz Biotechnology, sc-365001) was used in western blot knockout validation on human samples at 1:400 (fig 1c), in immunocytochemistry on human samples (fig 2e) and in immunohistochemistry on human samples at 1:200 (fig 5f). NAR Cancer (2021) ncbi
Articles Reviewed
  1. Bloniarz D, Adamczyk Grochala J, Lewinska A, Wnuk M. The lack of functional DNMT2/TRDMT1 gene modulates cancer cell responses during drug-induced senescence. Aging (Albany NY). 2021;13:15833-15874 pubmed publisher
  2. Zhu X, Wang X, Yan W, Yang H, Xiang Y, Lv F, et al. Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response. NAR Cancer. 2021;3:zcab010 pubmed publisher